, Japan
/Andre Benz from Unsplash

Japanese life insurers poised for earnings growth

Though other insurers have weaker profiles due to smaller operations, business diversification

Japan’s life insurers are expected to keep their overall strong capital adequacy for a while, supported by accumulated capital through hybrid debt issuance and significant unrealized gains on securities, Fitch Rating said.

Unlike in regions like the US and UK, there is less investor pressure in Japan for share buybacks and dividends, allowing insurers to build excess capital.

Fitch Ratings noted a wide range in the company profiles of Japanese life insurers. Dai-ichi Life stands out with a highly diversified global business, classifying it among the major global life insurers. 

In contrast, other insurers have weaker profiles due to smaller operations and limited business diversification.

Earnings for Japanese life insurers are expected to grow, driven by a recovery in underwriting profitability to pre-pandemic levels as mortality and morbidity losses from COVID-19 decreased substantially by March 2024. 

The change in Japan's "deemed hospitalisation" rule in May 2023 has also reduced related insurance payments, while a steadily declining average guaranteed yield supports a solid investment spread.

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.